Berapa harga Poolbeg Pharma PLC (POLB)

Harga Poolbeg Pharma PLC (POLB) adalah $0.11565963

Apa kapitalisasi pasar Poolbeg Pharma PLC (POLB)

Kapitalisasi pasar Poolbeg Pharma PLC (POLB) adalah $882.99K

Poolbeg Pharma PLC (POLB) Margin Operasi

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Tahun	Margin Operasi	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Margin Operasi

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Margin Operasi	Perbedaan Margin Operasi	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	38.97%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Lonza Group AG LONN.SW	0.00%	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	-	KR
UCB S.A. UCB.BR	31.23%	-	BE

Perusahaan

Margin Operasi

Perbedaan Margin Operasi

Negara